medigraphic.com
ISSN 2225-4676 (Electronic)

2018, Number 2

<< Back Next >>

Rev Cubana Neurol Neurocir 2018; 8 (2)

Cerebral venous thrombosis

Celorrio CSY, Palma BL, Rodríguez PLR

Language: Spanish
References: 52
Page: 1-23
PDF size: 310.23 Kb.


ABSTRACT

Objective: To identify the most relevant and advance aspects on epidemiology, etiology, etiopathogeny, diagnosis, treatment and prognosis of cerebral venous thrombosis.
Evidence acquisition: The bibliographic references were identified by means of the search in PubMed of the publications of the last five years in English or Spanish with the term “cerebral venous thrombosis” or “intracranial sinus thrombosis” and their variant in Spanish in open access articles. Only it checked the accessible article of free way.
Results: Multicenter studies have defined the frequency of this disease and the risk factors involved in the development of venous thrombosis. There is higher incidence of the disease in females and due to the use of oral contraceptives. In addition, large variety of permanent and transitory risk factors have been reported. Patients present very diverse clinical manifestations. Headache is the most frequent. Venography magnetic resonance imaging is the most useful diagnostic tool today also venography tomography can also be used. The therapeutic management aims at the elimination of the thrombus in the acute phase and the prevention of recurrences. During the acute phase, treatment of intracranial hypertension, hydrocephalus and epileptic seizures is indicated. Chronic anticoagulation depends on several factors that constitute, at the same time, prognostic factors.
Conclusions: It is important to identify cerebral venous thrombosis promptly in order to quickly initiate appropriate treatment, and avoid serious complications such as permanent neurological deficits or death. In the coming years, improvement of therapeutic guidelines should come up from new multicenter observational studies and more randomized specific clinical trials.


REFERENCES

  1. Patel SI, Obeid H, Matti L, Ramakrishna H, Shamoun FE. Cerebral Venous Thrombosis Current and Newer Anticoagulant Treatment Options. The Neurologist. 2015;20:80-8.

  2. Gokhale S, Lahoti SA. Therapeutic Advances in Understanding Pathophysiology and Treatment of Cerebral Venous Sinus Thrombosis. Am J Ther. 2014 Mar-Apr;21(2):137-9. doi: 10.1097/MJT.0b013e31822b561e.

  3. Luo Y, Tian X, Wang X. Diagnosis and Treatment of Cerebral Venous Thrombosis: A Review. Front Aging Neurosci. 2018;10:2. doi: 10.3389/fnagi.2018.00002.

  4. Coutinho JM. Cerebral venous thrombosis. J Thromb Haemost. 2015;13(Suppl. 1):S238-S44.

  5. Star M, Flaster M. Advances and controversies in the management of cerebral venous thrombosis. Neurol Clin. 2013;31:765-83.

  6. Zuluaga MI, Massaro M, Franco CA. Trombosis de senos venosos cerebrales: epidemiología, características clínicas, imagenología y pronóstico. Biomédica. 2015;35:196-203.

  7. Bushnell C, Saposnik G. Evaluation and Management of Cerebral Venous Thrombosis. Continuum (Minneap Minn). 2014;20(2 Cerebrovascular Disease):335-51.

  8. Méndez T, Boero A, Pérez Lago C. Trombosis Venosa Cerebral. Tendencias en Medicina. Mayo 2016;Año XXV(48):182-4.

  9. Ferro JM, Canhão P. Cerebral Venous Sinus Thrombosis: Update on Diagnosis and Management. Curr Cardiol Rep. 2014;16:523.

  10. Ferro J, Canhao P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35(3):664-70.

  11. Barinagarrementería F, Cantú C. Enfermedad Vascular Cerebral. México: Manual Moderno; 2003. p. 451-70.

  12. Cruz Arias O. Trombosis venosa cerebral. Rev med Costa Rica LXXIII. 2016;620:739-44.

  13. Guenthera G, Arauzb A. Trombosis venosa cerebral: aspectos actuales del diagnóstico y tratamiento. Neurología. 2011;26(8):488-98.

  14. Cura DM, Paulazzo M, Pailler JM, Campuzano S. Trombosis de los senos cerebrales. Comunicación de un caso. Intra Med Journal. 2014;3(2):1-2.

  15. Coutinho JM, Stam J, Canhao P, Barinagarrementeria F, Bousser MG, Ferro JM. Cerebral venous thrombosis in the absence of headache. Stroke. 2015 Jan;46(1):245-7. doi: 10.1161/STROKEAHA.114.007584.

  16. Geraldes R, Sousa PR, Fonseca AC, Falcão F, Canhão P, Pinho e Melo T. Nontraumatic convexity subarachnoid hemorrhage: different etiologies and outcomes. J Stroke Cerebrovasc Dis. 2014 Jan;23(1):e23-30. doi: 10.1016/j.jstrokecerebrovasdis.2013.08.005.

  17. Bentley JN, Figueroa RE, Vender JR. From presentation to follow up: diagnosis and treatment of cerebral venous thrombosis. Neurosurg Focus. 2009;27:E4.

  18. Tan FU, Tellioglu S, KocRS, Leventoglu A. Migraine-like headache in cerebral venous sinus thrombosis. Neurol Neurochir Pol. 2015;49:78-80.

  19. Dentali F, Squizzato A, Marchesi C, Bonzini M, Ferro JM, Ageno W. D-dimer testing in the diagnosis of cerebral vein thrombosis: a systematic review and a meta-analysis of the literature. J Thromb Haemost. 2012 Apr;10(4):582-9. doi: 10.1111/j.1538-7836.2012.04637.x.

  20. Ferro JM, Bousser MG, Canhão P, Coutinho JM, Crassard I, Dentali F, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology. Eur J Neurol. 2017 Oct;24(10):1203-13. doi: 10.1111/ene.13381.

  21. Hiltunen S, Putaala J, Haapaniemi E, Salonen O, Tatlisumak T. D-dimer and clinic radiologic features in cerebral venous thrombosis. J Neurol Sci. 2013;327(1-2):12-4. doi: 10.1016/j.jns.2013.01.033.

  22. Thorell SE, Parry-Jones AR, Punter M, Hurford R, Thachil J. Cerebral venous thrombosis: a primer for the haematologist. Blood Rev. 2015 Jan;29(1):45-50. doi: 10.1016/j.blre.2014.09.006.

  23. Lauw MN, Barco S, Coutinho JM, Middeldorp S. Cerebral venous thrombosis and thrombophilia: a systematic review and meta-analysis. Semin Thromb Hemost. 2013;39:913-27.

  24. Bonneville F. Imaging of cerebral venous thrombosis. Diagnostic and Interventional Imaging. 2014;95:1145-50.

  25. Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011 Apr;42(4):1158-92. doi: 10.1161/STR.0b013e31820a8364.

  26. Buyck PJ, De Keyzer F, Vanneste D, Wilms G, Thijs V, Demaerel P. CT density measurement and H:H ratio are useful in diagnosing acute cerebral venous sinus thrombosis. AJNR Am J Neuroradiol. 2013;34:1568-72.

  27. Coutinho JM, van den Berg R, Zuurbier SM, VanBavel E, Troost D, Majoie CB, et al. Small juxtacortical hemorrhages in cerebral venous thrombosis. Ann Neurol. 2014;75:908-16.

  28. Lauw MN, Barco S, Coutinho JM, Middeldorp S. Cerebral venous thrombosis and thrombophilia: a systematic review and metaanalysis. Semin Thromb Hemost. 2013;39:913-27.

  29. Coutinho JM, Ferro JM, Canhão P, Barinagarrementeria F, Cantú C, Bousser MG, et al. Cerebral venous and sinus thrombosis in women. Stroke. 2009;40(7):2356-61. doi: 10.1161/STROKEAHA.108.543884.

  30. Khan M, Wasay M, Menon B, Saadatnia M, Venketasubramanian N, Gunaratne P, et al. Pregnancy and puerperium related strokes in Asian women. J Stroke Cerebrovasc Dis. 2013 Nov;22(8):1393-8. doi: 10.1016/j.jstrokecerebrovasdis.2013.04.024.

  31. Canhão P, Abreu LF, Ferro JM, Ferro JM, Stam J, Bousser MG, et al. Safety of lumbar puncture in patients with cerebral venous thrombosis. Eur J Neurol. 2013;20:1075-80.

  32. Vale TC, Santos GC, Saturnino SF, Antunes Neto AS, Amâncio FF, Oliveira MA, et al. Weil syndrome: a rare cause of cerebral venous thrombosis. JAMA Neurol. 2014;71:238-9. doi: 10.1001/jamaneurol.2013.2175.

  33. Gulati D, Strbian D, Sundararajan S. Cerebral venous thrombosis: diagnosis and management. Stroke. 2014;45:e16-e18.

  34. Cundiff DK. Anticoagulants for cerebral venous thrombosis: harmful to patients? Stroke. 2014;45:298-304.

  35. Coutinho JM, Bousser MG, Stam J. Response to evidence-basis for anticoagulants for cerebral sinus venous thrombosis? Stroke. 2013;44:e68.

  36. Selim M. Cerebral venous thrombosis. Another heparin controversy. Stroke. 2014;45:89.

  37. Ghandehari K, Riasi HR, Noureddine A, Masoudinezhad S, Yazdani S, Mirzae MM, et al. Safety assessment of anticoagulation therapy in patients with hemorrhagic cerebral venous thrombosis. Iran J Neurol. 2013;12:87-91.

  38. Cundiff DK. Anticoagulants for Cerebral Venous Thrombosis: Harmful to Patients? Stroke. 2014 Jan;45(1):298-304. doi: 10.1161/STROKEAHA.113.003519.

  39. Siddiqui FM, Dandapat S, Banerjee C, Zuurbier SM, JohnsonM, Stam J, et al. Mechanical thrombectomy in cerebral venous thrombosis: a systematic review of 185 cases. Stroke. 2015;29:102-22.

  40. Coutinho JM, Ferro JM, Zuurbier SM, Mink MS, Canhão P, Crassard I, et al. Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial. Int J Stroke. 2013;8:135-40.

  41. Siddiqui FM, Dandapat S, Banerjee C, Zuurbier SM, Johnson M, Stam J, et al. Mechanical thrombectomy in cerebral venous thrombosis: systematic review of 185 cases. Stroke. 2015 May;46(5):1263-8. doi: 10.1161/STROKEAHA.114.007465.

  42. Aaron S, Alexander M, Moorthy RK, Mani S, Mathew V, Patil AK, et al. Decompressive craniectomy in cerebral venous thrombosis: a single centre experience. J Neurol Neurosurg Psychiatry. 2013;84(9):995-1000.

  43. Lobo S, Ferro JM, Barinagarrementeria F, Bousser MG, Canhão P, Stam J, et al. Shunting in acute cerebral venous thrombosis: a systematic review. Cerebrovasc Dis. 2014;37(1):38-42. doi: 10.1159/000356524.

  44. Raza E, Shamim MS, Wadiwala MF, Ahmed B, Kamal AK. Decompressive surgery for malignant cerebral venous sinus thrombosis: a retrospective case series from Pakistan and comparative literature review. J Stroke Cerebrovasc Dis. 2014;23:e13-e22.

  45. Mahale R, Mehta A, Varma RG, Hegde AS, Acharya PT, Srinivasa R. Decompressive surgery in malignant cerebral venous sinus thrombosis: what predicts its outcome? J Thromb Thrombolysis. 2017;43:530-9. doi: 10.1007/s11239-017-1489-x

  46. Davoudi V, Keyhanian K, Saadatnia M. Risk factors for remote seizure development in patients with cerebral vein and dural sinus thrombosis. Seizure. 2014;23:135-9. 47. Price M, Günther A, Kwan JS. Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis. Cochrane Database Syst Rev. 2014;(8):CD005501.

  47. Murdock J, Tzu JH, Schatz NJ, Lee WW. Optic nerve sheath fenestration for the treatment of papilledema secondary to cerebral venous thrombosis. J Neuroophthalmol. 2014;34(1):67-9. doi: 10.1097/WNO.0000000000000087

  48. Zuurbier SM, van den Beg R, Troost D, Majoie CB, Stam J, Coutinho J. Hydrocephalus in cerebral venous thrombosis. J Neurol. 2015;262:931-7.

  49. Weerasinghe D, Lueck CJ. Septic Cavernous Sinus Thrombosis: Case Report and Review of the Literature. Neuroophthalmology. 2016;40(6):263-76.

  50. Ferro JM. EXCOA-CVT study: the benefit of extending oral anticoagulation treatment after acute Cerebral Vein Thrombosis. ISRCTN; 2014. doi: 10.1186/isrctn25644448

  51. Geisbusch C, Richter D, Herweh C, Ringleb PA, Nagel S. Novel factor xa inhibitor for the treatment of cerebral venous and sinus thrombosis: first experience in 7 patients. Stroke. 2014;45:2469-71.

  52. Mendonca MD, Barbosa R, Cruz-E-Silva V, Calado S, Viana-Baptista M. Oral direct thrombin inhibitor as an alternative in the management of cerebral venous thrombosis: a series of 15 patients. Int J Stroke. 2015;10:1115-8.




2020     |     www.medigraphic.com